γH2AX DNA Damage Detection Kit: Precise DNA Double-Strand Break Assay

Executive Summary: The γH2AX DNA Damage Detection Kit (Mouse mAb/Red) is a specialized tool for detecting DNA double-strand breaks (DSBs) via immunofluorescence, using a mouse monoclonal antibody specific for γ-H2AX—phosphorylated at serine 139, a recognized DNA damage biomarker (Xu et al., 2026). The kit enables visualization of DNA damage foci in human, mouse, or rat tissues, supporting research into genomic instability, apoptosis, and genotoxicity. It employs a red-fluorescent secondary antibody for DSB detection and DAPI for nuclear staining, optimizing sensitivity for fluorescence microscopy and high-content screening (see also). Reagents are quality-controlled for reproducibility, with specific storage conditions to ensure signal integrity. The kit is validated for integration into DNA damage response pathway analysis, apoptosis assays, and genotoxicity testing workflows.

Biological Rationale

DNA double-strand breaks (DSBs) constitute one of the most critical forms of genomic damage. Unrepaired or misrepaired DSBs can lead to genomic instability, carcinogenesis, or cell death (Xu et al., 2026). The histone H2A variant H2AX is rapidly phosphorylated at serine 139 (γ-H2AX) by ATM and ATR kinases in response to DSBs. γ-H2AX foci form at break sites within minutes of damage induction, acting as a sensitive biomarker for DSBs and signaling the recruitment of DNA repair machinery (see related). Detection and quantification of γ-H2AX enable researchers to assess DNA damage, repair kinetics, and the efficacy of genotoxic agents or radiotherapy (for advanced applications).

Mechanism of Action of γH2AX DNA Damage Detection Kit (Mouse mAb/Red)

The kit utilizes a mouse monoclonal antibody targeting γ-H2AX (phospho-Ser139), enabling selective binding to DSB-associated chromatin. Upon fixation and permeabilization, the primary antibody binds γ-H2AX foci. A Cy5-conjugated anti-mouse secondary antibody confers red fluorescence, providing high-contrast visualization under appropriate filter sets. DAPI is included for nuclear counterstaining (excitation/emission: ~358/461 nm), allowing precise localization of foci within cell nuclei. The kit supports multiplexing in human, mouse, or rat cells and tissues.

• Primary antibody: Mouse monoclonal, high affinity for γ-H2AX (Ser139).
• Secondary antibody: Cy5-conjugated anti-mouse IgG (red fluorescence; excitation/emission: ~650/670 nm).
• Counterstain: DAPI for nuclear visualization.
• Buffers: Optimized for immunofluorescence workflow; include fixation, wash, and blocking solutions.

All fluorescent reagents require protection from light and are stable at 4°C or -20°C as recommended by APExBIO.

Evidence & Benchmarks

• γ-H2AX foci formation correlates quantitatively with DSB induction, with signal detectable within minutes post-exposure to ionizing radiation (Xu et al. 2026, https://doi.org/10.2147/IJN.S571116).
• The kit enables detection of DSBs in cells exposed to both conventional and FLASH-RT radiotherapy, supporting translational cancer research (Xu et al. 2026, https://doi.org/10.2147/IJN.S571116).
• High-content screening using γH2AX immunofluorescence provides reproducible, quantitative results in apoptosis and genotoxicity assays at single-cell resolution (https://sn-38.com/...).
• The assay is validated in multiple species (human, mouse, rat), broadening its application in preclinical research (product page).
• In a recent benchmark, enhanced γ-H2AX positivity was observed in tumor cells treated with EGCG nanoparticle radiosensitizers, confirming assay sensitivity to DNA damage modulation (Xu et al. 2026, https://doi.org/10.2147/IJN.S571116).

Applications, Limits & Misconceptions

The K2275 kit is extensively used in:

• DNA double-strand break detection and quantitation.
• Assessment of DNA damage response (DDR) pathways, including ATM/ATR kinase signaling.
• Apoptosis and genotoxicity research in cancer and toxicology studies.
• Evaluation of DNA repair inhibitors or radiosensitizers in preclinical models.

Unlike some methods, γH2AX detection provides spatial and quantitative resolution of DSBs at the single-cell level, but does not distinguish DSB etiology (e.g., radiomimetic drugs vs. oxidative stress) without additional markers. For a deeper mechanistic discussion of γ-H2AX immunofluorescence and how this kit advances beyond prior tools, see this article—which this review updates by incorporating recent radiotherapy and immune modulation data.

Common Pitfalls or Misconceptions

• γ-H2AX positivity is not exclusive to DSBs induced by radiation; other genotoxic stresses can yield similar signals.
• The kit does not measure DNA repair kinetics directly; time-course sampling is required for dynamic studies.
• High background fluorescence may occur if wash steps are insufficient or light exposure is excessive.
• Kit is not validated for formalin-fixed paraffin-embedded (FFPE) tissues; frozen sections or cell cultures are recommended.
• Quantitative comparison across experiments requires normalization to cell number and imaging parameters.

Workflow Integration & Parameters

The γH2AX DNA Damage Detection Kit is optimized for integration into standard cell biology and molecular oncology workflows. Recommended protocol steps include:

1. Sample preparation: Adherent cells fixed with provided solution (typically 10–15 min at room temperature).
2. Permeabilization and blocking: Manufacturer's buffer for 30 min to reduce background.
3. Primary antibody incubation: 1–2 hours at room temperature or overnight at 4°C.
4. Secondary antibody (Cy5 anti-mouse) incubation: 1 hour, protected from light.
5. DAPI counterstaining: 5 min at room temperature.
6. Mount and image using appropriate filter sets for DAPI and Cy5 channels.

For high-content or automated microscopy, batch processing and image analysis software can quantify γ-H2AX foci per nucleus. All reagents should be stored as indicated in the manual (APExBIO product manual), with light-sensitive components protected at all times.

Conclusion & Outlook

The γH2AX DNA Damage Detection Kit (Mouse mAb/Red) from APExBIO sets a benchmark for sensitive, reproducible DSB detection and quantification in cellular and tissue samples. Its robust immunofluorescence workflow supports advanced research in DNA damage response, genotoxicity, and translational cancer therapeutics. As new radiosensitizers and immunotherapies emerge, this kit remains integral to evaluating genomic instability and therapeutic efficacy. For a broader perspective on how this kit compares with other approaches, see this review; this article clarifies the integration of γ-H2AX detection in radiotherapy-immunotherapy research. Future directions include multiplexing with additional DDR markers and adaptation to high-throughput screening platforms.